HomeCompareAAPGV vs EPRT

AAPGV vs EPRT: Dividend Comparison 2026

AAPGV yields 11.51% · EPRT yields 3.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EPRT wins by $21.6K in total portfolio value· pulled ahead in Year 7
10 years
AAPGV
AAPGV
● Live price
11.51%
Share price
$17.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.8K
Annual income
$2,362.57
Full AAPGV calculator →
EPRT
EPRT
● Live price
3.97%
Share price
$30.36
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.3K
Annual income
$13,170.85
Full EPRT calculator →

Portfolio growth — AAPGV vs EPRT

📍 EPRT pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAAPGVEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AAPGV + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AAPGV pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AAPGV
Annual income on $10K today (after 15% tax)
$978.14/yr
After 10yr DRIP, annual income (after tax)
$2,008.18/yr
EPRT
Annual income on $10K today (after 15% tax)
$337.37/yr
After 10yr DRIP, annual income (after tax)
$11,195.22/yr
At 15% tax rate, EPRT beats the other by $9,187.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AAPGV + EPRT for your $10,000?

AAPGV: 50%EPRT: 50%
100% EPRT50/50100% AAPGV
Portfolio after 10yr
$53.5K
Annual income
$7,766.72/yr
Blended yield
14.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

AAPGV
No analyst data
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+16.9% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AAPGV buys
0
EPRT buys
0
No recent congressional trades found for AAPGV or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAAPGVEPRT
Forward yield11.51%3.97%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$42.8K$64.3K
Annual income after 10y$2,362.57$13,170.85
Total dividends collected$17.5K$38.7K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: AAPGV vs EPRT ($10,000, DRIP)

YearAAPGV PortfolioAAPGV Income/yrEPRT PortfolioEPRT Income/yrGap
1$11,851$1,150.75$11,212$512.01+$639.00AAPGV
2$13,955$1,274.51$12,689$692.09+$1.3KAAPGV
3$16,334$1,402.61$14,521$944.30+$1.8KAAPGV
4$19,012$1,534.36$16,841$1,302.88+$2.2KAAPGV
5$22,012$1,669.06$19,841$1,821.64+$2.2KAAPGV
6$25,359$1,806.01$23,818$2,587.47+$1.5KAAPGV
7← crossover$29,078$1,944.49$29,230$3,744.65$152.00EPRT
8$33,198$2,083.84$36,816$5,540.38$3.6KEPRT
9$37,745$2,223.40$47,806$8,413.17$10.1KEPRT
10$42,750$2,362.57$64,324$13,170.85$21.6KEPRT

AAPGV vs EPRT: Complete Analysis 2026

AAPGVStock

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor; APG-265, a MDM2 protein degrader; and UBX1967/1325, which are Bcl-2 inhibitors. In addition, it is also involved in medical research and development; clinical development; clinical trial operation; venture capital investment; rental services; and science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.

Full AAPGV Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this AAPGV vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AAPGV vs SCHDAAPGV vs JEPIAAPGV vs OAAPGV vs KOAAPGV vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.